• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名患有重症新型冠状病毒肺炎的患者,通过恢复期血浆治疗成功康复。

A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma.

作者信息

Einollahi Behzad, Cegolon Luca, Abolghasemi Hassan, Imanizadeh Sina, Bahramifar Ali, Zhao Shi, Jafari Ramezan, Javanbakht Mohammad

机构信息

Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Local Health Unit N. 2 "Marca Trevigiana", Public Health Department, Treviso, Italy.

出版信息

Transfus Apher Sci. 2020 Dec;59(6):102995. doi: 10.1016/j.transci.2020.102995. Epub 2020 Nov 5.

DOI:10.1016/j.transci.2020.102995
PMID:33183986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7644253/
Abstract

We present a critically ill patient affected by COVID-19, whose chest computed tomography (CT) scan featured lung consolidations and severe patchy ground-glass opacitie. On day 3 since hospital admission the patient was placed on convalescent plasma treatment. A combined treatment with supportive care, hemoperfusion and convalescent plasma successfully managed to save the patient's life. Convalescent plasma probably contributed to heal this patient and should always be considered in the management of critically ill COVID-19 cases.

摘要

我们报告了一名患有新冠肺炎的重症患者,其胸部计算机断层扫描(CT)显示肺部实变和严重的斑片状磨玻璃影。入院第3天,该患者接受了恢复期血浆治疗。综合支持治疗、血液灌流和恢复期血浆治疗成功挽救了患者生命。恢复期血浆可能有助于治愈该患者,在重症新冠肺炎病例的治疗中应始终予以考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad7/7644253/f5b3452b5e53/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad7/7644253/f5b3452b5e53/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad7/7644253/f5b3452b5e53/gr1_lrg.jpg

相似文献

1
A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma.一名患有重症新型冠状病毒肺炎的患者,通过恢复期血浆治疗成功康复。
Transfus Apher Sci. 2020 Dec;59(6):102995. doi: 10.1016/j.transci.2020.102995. Epub 2020 Nov 5.
2
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
3
Convalescent plasma may not be an effective treatment for severe and critically ill covid-19 patients: A Systematic Review & Meta-Analysis of Randomized Controlled Trials.恢复期血浆可能不是治疗严重和危重新冠肺炎患者的有效方法:一项随机对照试验的系统评价和荟萃分析。
Heart Lung. 2022 May-Jun;53:51-60. doi: 10.1016/j.hrtlng.2022.01.019. Epub 2022 Feb 1.
4
[Successful administration of convalescent plasma in critically ill COVID-19 patients in Hungary: the first two cases].[匈牙利重症 COVID-19 患者康复期血浆治疗成功:首例两例]
Orv Hetil. 2020 Jul;161(27):1111-1121. doi: 10.1556/650.2020.31901.
5
The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients.恢复期血浆治疗危重症 COVID-19 患者的疗效。
Medicina (Kaunas). 2021 Mar 11;57(3):257. doi: 10.3390/medicina57030257.
6
Rethinking the role of COVID-19 convalescent plasma in the critically ill.重新思考新冠康复者血浆在危重症患者中的作用。
Transfus Apher Sci. 2023 Feb;62(1):103521. doi: 10.1016/j.transci.2022.103521. Epub 2022 Aug 4.
7
Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.随机临床试验评估 COVID-19 住院患者使用恢复期血浆的安全性和疗效(PERUCONPLASMA):一项随机对照试验研究方案的结构化总结。
Trials. 2021 May 17;22(1):342. doi: 10.1186/s13063-021-05189-6.
8
The Successful Recovery of a Critically Ill COVID-19 Patient, Following the Combination of Therapeutic Plasma Exchange and Convalescent Plasma Transfusion: A Case Report.《COVID-19 危重症患者接受治疗性血浆置换联合恢复期血浆输注后成功康复:一例报告》。
Medicina (Kaunas). 2022 Aug 12;58(8):1088. doi: 10.3390/medicina58081088.
9
INFUSION OF CONVALESCENT PLASMA IS ASSOCIATED WITH CLINICAL IMPROVEMENT IN CRITICALLY ILL PATIENTS WITH COVID-19: A PILOT STUDY.新冠康复期血浆输注与危重症COVID-19患者临床改善相关:一项初步研究。
Rev Invest Clin. 2020;72(3):159-164. doi: 10.24875/RIC.20000237.
10
Convalescent plasma treatment of critically ill intensive care COVID-19 patients.恢复期血浆治疗危重症 COVID-19 患者的 ICU 治疗。
Transfusion. 2021 May;61(5):1394-1403. doi: 10.1111/trf.16392. Epub 2021 Apr 8.

引用本文的文献

1
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis.恢复期血浆疗法对 COVID-19 患者死亡率的影响:系统评价和荟萃分析。
Mayo Clin Proc. 2021 May;96(5):1262-1275. doi: 10.1016/j.mayocp.2021.02.008. Epub 2021 Feb 17.
2
IgV somatic mutation of human anti-SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity.人类抗 SARS-CoV-2 单克隆抗体的 IgV 体细胞突变决定了中和作用和反应广度。
JCI Insight. 2021 May 10;6(9):147386. doi: 10.1172/jci.insight.147386.

本文引用的文献

1
Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients.低剂量放射疗法与恢复期血浆:一种混合方法如何使新冠肺炎患者的益处最大化。
J Biomed Phys Eng. 2020 Aug 1;10(4):387-394. doi: 10.31661/jbpe.v0i0.2006-1125. eCollection 2020 Aug.
2
Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma.一名接受康复期血浆治疗的 COVID-19 感染淋巴瘤患者出现病毒长时间脱落。
Transfus Apher Sci. 2020 Oct;59(5):102871. doi: 10.1016/j.transci.2020.102871. Epub 2020 Jul 3.
3
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study.
康复期血浆治疗新型冠状病毒肺炎感染的临床疗效:一项多中心临床研究的结果
Transfus Apher Sci. 2020 Oct;59(5):102875. doi: 10.1016/j.transci.2020.102875. Epub 2020 Jul 15.
4
Therapeutic plasma exchange in adults with severe COVID-19 infection.成人严重 COVID-19 感染的治疗性血浆置换。
Int J Infect Dis. 2020 Oct;99:214-218. doi: 10.1016/j.ijid.2020.06.064. Epub 2020 Jun 23.
5
Hypothesis to explain the severe form of COVID-19 in Northern Italy.解释意大利北部新冠病毒肺炎严重形式的假说。
BMJ Glob Health. 2020 Jun;5(6). doi: 10.1136/bmjgh-2020-002564.
6
Early safety indicators of COVID-19 convalescent plasma in 5000 patients.5000 例 COVID-19 恢复期血浆治疗的早期安全性指标。
J Clin Invest. 2020 Sep 1;130(9):4791-4797. doi: 10.1172/JCI140200.
7
Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis.一名患有播散性肺结核的骨髓增生异常综合征新冠患者的恢复期(免疫)血浆治疗
Transfus Apher Sci. 2020 Oct;59(5):102821. doi: 10.1016/j.transci.2020.102821. Epub 2020 May 29.
8
Current studies of convalescent plasma therapy for COVID-19 may underestimate risk of antibody-dependent enhancement.目前关于COVID-19恢复期血浆疗法的研究可能低估了抗体依赖增强作用的风险。
J Clin Virol. 2020 Jun;127:104388. doi: 10.1016/j.jcv.2020.104388. Epub 2020 Apr 28.
9
COVID-19 convalescent plasma transfusion.新型冠状病毒肺炎康复者恢复期血浆输注
Hematol Transfus Cell Ther. 2020 Apr-Jun;42(2):113-115. doi: 10.1016/j.htct.2020.04.003. Epub 2020 Apr 17.
10
Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19.COVID-19 危重症患者采用血浆置换联合静脉注射免疫球蛋白治疗获得成功。
Int J Antimicrob Agents. 2020 Aug;56(2):105974. doi: 10.1016/j.ijantimicag.2020.105974. Epub 2020 Apr 13.